Compare Mutual Funds
Risk
Very High
-
Rating
2.0
-
Min SIP Amount
₹100
-
Expense Ratio
2.25
-
NAV
₹36.70
-
Fund Started
20 Jun 2019
-
Fund Size
₹900.87 Cr
-
Exit Load
Exit load of 1% if redeemed within 30 days.
-
1 Year
10.61%
-
3 Year
23.78%
-
5 Year
12.64%
-
Equity
98.61%
-
Cash
1.39%
-
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.17% |
Apollo Hospitals Enterprise Ltd. | 7.20% |
Torrent Pharmaceuticals Ltd. | 4.76% |
JB Chemicals & Pharmaceuticals Ltd. | 4.71% |
Aurobindo Pharma Ltd. | 4.49% |
Ajanta Pharma Ltd. | 4.05% |
Lupin Ltd. | 4.00% |
Mankind Pharma Ltd. | 3.88% |
Fortis Healthcare Ltd. | 3.87% |
Abbott India Ltd. | 3.65% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.
-
Launch Date
20 Jun 2019
-
